Azithromycin dihydrate's extended tissue half-life and intracellular penetration give it a distinct advantage in veterinary respiratory disease management, where a single-dose or short-course regimen can replace longer treatments. It is increasingly adopted in small animal practice for chronic rhinitis, periodontal infections, and Mycoplasma-associated respiratory syndromes.
Quick Facts
| CAS Number | 117772-70-0 |
|---|---|
| Molecular Formula | C38H72N2O12 · 2H2O |
| Molecular Weight | 785.02 |
| Pharmacopoeia | USP, EP, CP |
| Packaging | 25 KG/DRUM |
Product Overview
Azithromycin Dihydrate is a macrolide antibiotic for veterinary use with an expanded spectrum and improved pharmacokinetic profile. Its long tissue half-life enables short treatment courses, improving compliance in livestock management.
Azithromycin binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis. Its unique pharmacokinetics include extensive tissue distribution and a prolonged terminal half-life. Excellent activity against respiratory pathogens, Chlamydia, and Mycoplasma makes it valuable across poultry, swine, cattle, and companion animal practice.
Quality Specifications
| Purity | As per USP monograph |
|---|---|
| Residual Solvents | Compliant with ICH Q3C |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |
Veterinary Applications
- Poultry chronic respiratory disease: Mycoplasma gallisepticum and M. synoviae control
- Swine respiratory complex: Treatment of bacterial pneumonia and pleuropneumonia
- Bovine respiratory disease: Management of shipping fever and pneumonia in cattle
- Canine and feline respiratory infections: Upper and lower respiratory tract infections
- Sheep and goat pneumonia: Treatment of respiratory infections in small ruminants